Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $8.29 in the prior trading day, EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) closed at $8.34, up 0.60%. In other words, the price has increased by $0.60 from its previous closing price. On the day, 0.62 million shares were traded. EYPT stock price reached its highest trading level at $8.52 during the session, while it also had its lowest trading level at $8.21.
Ratios:
Our goal is to gain a better understanding of EYPT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.69 and its Current Ratio is at 4.75. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on August 28, 2024, initiated with a Buy rating and assigned the stock a target price of $15.
On January 22, 2024, JP Morgan started tracking the stock assigning a Overweight rating and target price of $35.
On November 02, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $20.Mizuho initiated its Buy rating on November 02, 2023, with a $20 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 20 ’24 when DICICCO WENDY F bought 2,567 shares for $7.79 per share. The transaction valued at 19,997 led to the insider holds 9,967 shares of the business.
ANDO GORAN bought 5,000 shares of EYPT for $39,750 on Aug 21 ’24. The Director now owns 13,150 shares after completing the transaction at $7.95 per share. On Aug 19 ’24, another insider, Zaderej Karen L., who serves as the Director of the company, bought 12,500 shares for $7.98 each. As a result, the insider paid 99,750 and bolstered with 16,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EYPT now has a Market Capitalization of 446341792 and an Enterprise Value of 189387872. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.86 while its Price-to-Book (P/B) ratio in mrq is 1.91. Its current Enterprise Value per Revenue stands at 3.758 whereas that against EBITDA is -1.962.
Stock Price History:
Over the past 52 weeks, EYPT has reached a high of $30.99, while it has fallen to a 52-week low of $5.67. The 50-Day Moving Average of the stock is -5.61%, while the 200-Day Moving Average is calculated to be -48.94%.
Shares Statistics:
The stock has traded on average 710.58K shares per day over the past 3-months and 624210 shares per day over the last 10 days, according to various share statistics. A total of 53.52M shares are outstanding, with a floating share count of 49.50M. Insiders hold about 7.51% of the company’s shares, while institutions hold 103.64% stake in the company. Shares short for EYPT as of 1724976000 were 9111785 with a Short Ratio of 12.82, compared to 1722384000 on 9546661. Therefore, it implies a Short% of Shares Outstanding of 9111785 and a Short% of Float of 19.96.
